Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
Bandhan Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
21 companies both funds hold · largest common part first
Only in A
14 companies · largest first
- Shilpa Medicare Limited4.46%
- Eris Lifesciences Limited2.34%
- Novartis India Limited2.01%
- Pfizer Limited1.65%
- Sanofi India Limited1.60%
- Healthcare Global Enterprises Limited1.42%
- Thyrocare Technologies Limited1.40%
- Jubilant Pharmova Limited1.35%
- Sai Parenterals Limited1.23%
- Alivus Life Sciences Limited1.23%
- AstraZeneca Pharma India Limited1.22%
- Orchid Pharma Limited1.21%
- Medi Assist Healthcare Services Limited0.89%
- Viyash Scientific Limited0.83%
Only in B
23 companies · largest first
- Laurus Labs Limited5.72%
- Fortis Healthcare Limited2.98%
- Alkem Laboratories Limited2.31%
- Mankind Pharma Limited2.10%
- Biocon Limited1.91%
- Krishna Institute of Medical Sciences Limited1.48%
- Aster DM Quality Care Limited1.38%
- Neuland Laboratories Limited1.36%
- Wockhardt Limited1.30%
- Acutaas Chemicals Limited1.26%
- Abbott India Limited1.04%
- Piramal Pharma Limited0.95%
- Granules India Limited0.93%
- Onesource Specialty Pharma Limited0.89%
- Anthem Biosciences Limited0.69%
And 8 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 90.6% | 100.0% | -9.37 pp |
| Not classified | 9.4% | 0.0% | +9.37 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →